Pharmaceutical Industry

This Feb. 19, 2013, photo shows OxyContin pills arranged for a photo at a pharmacy, in Montpelier, Vt. The wealthy family who owns the company that makes OxyContin says Massachusetts got the facts wrong in a lawsuit. Legal papers made public Tuesday, April 2, 2019, represent the first time the Sackler family, who owns the Connecticut-based Purdue Pharma, has responded in court to allegations about its role in the opioid crisis.

Healthcare

OxyContin maker Purdue to settle with Justice Department for more than $8B for role in opioid crisis

Cassidy Morrison -

October 21, 2020 3:31 pm

Democratic presidential candidate Sen. Kamala Harris, D-Calif., speaks at a Service Employees International Union forum on labor issues, Saturday, April 27, 2019, in Las Vegas.

Editorials

Paused trial shows that fearmongering over ‘Trump vaccine’ was both dumb and harmful

Washington Examiner -

October 15, 2020 4:00 am

Healthcare

Hospitalizations reach highest in six weeks, while infection rates climb in 13 states

Cassidy Morrison, David Hogberg -

October 13, 2020 11:07 pm

Healthcare

Eli Lilly antibody treatment trial put on pause due to safety concerns

Cassidy Morrison -

October 13, 2020 7:43 pm

In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass.

Economy

Include Puerto Rico in the onshoring of pharmaceuticals

Mario Lopez -

October 13, 2020 4:19 pm

A lab technician working a bottle containing for COVID-19 vaccine testing at Chula Vaccine Research Center, run by Chulalongkorn University in Bangkok, Thailand, Monday, May 25, 2020. Thai health officials said that scientists in Thailand have had promising results in testing a COVID-19 vaccine candidate on mice, and have begun testing on monkeys.

Healthcare

‘Unexplained illness’ puts Johnson & Johnson coronavirus vaccine study on pause

Zach Halaschak -

October 13, 2020 1:50 am

Healthcare

Hesitancy a growing obstacle to coronavirus vaccine

Cassidy Morrison, David Hogberg -

October 12, 2020 11:03 pm

Healthcare

In the right population, hydroxychloroquine works. So why are people still up in arms?

alan-c-herman -

September 28, 2020 3:10 pm

President Trump signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals. (AP Photo/Andrew Harnik, File)

Healthcare

FDA moved at warp speed on COVID-19 vaccine, but the precedent may not stick

David Hogberg -

September 17, 2020 10:30 am

Bill Gates, chairman of the Bill & Melinda Gates Foundation, attends the "Africa Leadership Meeting - Investing in Health Outcomes" held at a hotel in Addis Ababa, Ethiopia Saturday, Feb. 9, 2019.

Healthcare

Bill Gates says FDA has lost credibility on coronavirus vaccines

Cassidy Morrison -

September 15, 2020 1:47 pm

1...495051...159 Page 50 of 159

Tag: Pharmaceutical Industry

OxyContin maker Purdue to settle with Justice Department for more than $8B for role in opioid crisis

Paused trial shows that fearmongering over ‘Trump vaccine’ was both dumb and harmful

Hospitalizations reach highest in six weeks, while infection rates climb in 13 states

Eli Lilly antibody treatment trial put on pause due to safety concerns

Include Puerto Rico in the onshoring of pharmaceuticals

‘Unexplained illness’ puts Johnson & Johnson coronavirus vaccine study on pause

Hesitancy a growing obstacle to coronavirus vaccine

In the right population, hydroxychloroquine works. So why are people still up in arms?

FDA moved at warp speed on COVID-19 vaccine, but the precedent may not stick

Bill Gates says FDA has lost credibility on coronavirus vaccines

NEWS

POLICY

COMMENTARY

RESTORING AMERICA